Cargando…

Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy

PURPOSE: Bruton’s tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA nephropathy (IgAN) has not yet been elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jie, Wang, Yan, Qi, Xiangming, Wu, Yonggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192408/
https://www.ncbi.nlm.nih.gov/pubmed/33389462
http://dx.doi.org/10.1007/s11255-020-02733-2
_version_ 1783706055041089536
author Wei, Jie
Wang, Yan
Qi, Xiangming
Wu, Yonggui
author_facet Wei, Jie
Wang, Yan
Qi, Xiangming
Wu, Yonggui
author_sort Wei, Jie
collection PubMed
description PURPOSE: Bruton’s tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA nephropathy (IgAN) has not yet been elucidated. The purpose of this research was to investigate the role of BTK activation in macrophages in IgAN. METHODS: Peripheral blood and renal tissue samples were collected from 63 patients with IgAN, and peritumoral normal tissues were collected from 20 patients after surgical resection of renal tumor for use as control. Additionally, 20 healthy volunteers were recruited as control. The levels of BTK, CD68, phosphorylated BTK (pBTK), phosphorylated NF-κB (p-NF-κB p65), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and monocyte chemotactic protein (MCP)-1 were measured by immunohistochemistry (IHC), real-time polymerase chain reaction (RT-PCR), western blotting, and enzyme-linked immunosorbent assay (ELISA). RESULTS: Compared to peritumoral normal tissues, the expression levels of CD68 and BTK were significantly increased in IgAN group (p < 0.001) and the differences between M0 and M1, E0 and E1, S0 and S1, T0 and T1-2, C0 and C1-2 were statistically significant in the updated Oxford Classification (p < 0.05). Also, CD68 and BTK were positively correlated with Katafuchi semi-quantitative glomerular and tubulointerstitial scores (r = 0.580, 0.637 and 0.442, 0.489, respectively, p < 0.05). The expression of BTK was significantly higher in C3b- and C4d-positive renal tissues of patients with IgAN (p < 0.05). In addition, BTK was positively correlated with 24-h urine protein, serum creatinine levels (r = 0.456 and 0.453, respectively, p < 0.001), and negatively correlated with serum albumin (r = 0.357, p < 0.05). The intensity of expression of pBTK and p-NF-κB p65 was observably increased in renal tissues and monocytes of patients with IgAN compared to the control group. The results of IHC, RT-PCR, and ELISA indicated that the levels of TNF-ɑ, IL-1β, and MCP-1 were markedly increased in the IgAN group (p < 0.05). CONCLUSION: The results of this study indicate that activation of BTK in macrophages may play an important role in promoting the progression of renal inflammation in IgAN.
format Online
Article
Text
id pubmed-8192408
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-81924082021-06-28 Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy Wei, Jie Wang, Yan Qi, Xiangming Wu, Yonggui Int Urol Nephrol Nephrology - Original Paper PURPOSE: Bruton’s tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA nephropathy (IgAN) has not yet been elucidated. The purpose of this research was to investigate the role of BTK activation in macrophages in IgAN. METHODS: Peripheral blood and renal tissue samples were collected from 63 patients with IgAN, and peritumoral normal tissues were collected from 20 patients after surgical resection of renal tumor for use as control. Additionally, 20 healthy volunteers were recruited as control. The levels of BTK, CD68, phosphorylated BTK (pBTK), phosphorylated NF-κB (p-NF-κB p65), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and monocyte chemotactic protein (MCP)-1 were measured by immunohistochemistry (IHC), real-time polymerase chain reaction (RT-PCR), western blotting, and enzyme-linked immunosorbent assay (ELISA). RESULTS: Compared to peritumoral normal tissues, the expression levels of CD68 and BTK were significantly increased in IgAN group (p < 0.001) and the differences between M0 and M1, E0 and E1, S0 and S1, T0 and T1-2, C0 and C1-2 were statistically significant in the updated Oxford Classification (p < 0.05). Also, CD68 and BTK were positively correlated with Katafuchi semi-quantitative glomerular and tubulointerstitial scores (r = 0.580, 0.637 and 0.442, 0.489, respectively, p < 0.05). The expression of BTK was significantly higher in C3b- and C4d-positive renal tissues of patients with IgAN (p < 0.05). In addition, BTK was positively correlated with 24-h urine protein, serum creatinine levels (r = 0.456 and 0.453, respectively, p < 0.001), and negatively correlated with serum albumin (r = 0.357, p < 0.05). The intensity of expression of pBTK and p-NF-κB p65 was observably increased in renal tissues and monocytes of patients with IgAN compared to the control group. The results of IHC, RT-PCR, and ELISA indicated that the levels of TNF-ɑ, IL-1β, and MCP-1 were markedly increased in the IgAN group (p < 0.05). CONCLUSION: The results of this study indicate that activation of BTK in macrophages may play an important role in promoting the progression of renal inflammation in IgAN. Springer Netherlands 2021-01-03 2021 /pmc/articles/PMC8192408/ /pubmed/33389462 http://dx.doi.org/10.1007/s11255-020-02733-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Nephrology - Original Paper
Wei, Jie
Wang, Yan
Qi, Xiangming
Wu, Yonggui
Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title_full Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title_fullStr Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title_full_unstemmed Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title_short Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
title_sort enhanced bruton’s tyrosine kinase activity in the kidney of patients with iga nephropathy
topic Nephrology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192408/
https://www.ncbi.nlm.nih.gov/pubmed/33389462
http://dx.doi.org/10.1007/s11255-020-02733-2
work_keys_str_mv AT weijie enhancedbrutonstyrosinekinaseactivityinthekidneyofpatientswithiganephropathy
AT wangyan enhancedbrutonstyrosinekinaseactivityinthekidneyofpatientswithiganephropathy
AT qixiangming enhancedbrutonstyrosinekinaseactivityinthekidneyofpatientswithiganephropathy
AT wuyonggui enhancedbrutonstyrosinekinaseactivityinthekidneyofpatientswithiganephropathy